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ABSTRACT
In vitro assays are widely employed to obtain intrinsic clearance estimates used in toxicokinetic modeling efforts. However, the
reliability of these methods is seldom reported. Here we describe the results of an international ring trial designed to evaluate
two in vitro assays used to measure intrinsic clearance in rainbow trout. An important application of these assays is to predict
the effect of biotransformation on chemical bioaccumulation. Six laboratories performed substrate depletion experiments
with cyclohexyl salicylate, fenthion, 4-n-nonylphenol, deltamethrin, methoxychlor, and pyrene using cryopreserved
hepatocytes and liver S9 fractions from trout. Variability within and among laboratories was characterized as the percent
coefficient of variation (CV) in measured in vitro intrinsic clearance rates (CLIN VITRO, INT; ml/h/mg protein or 10
6 cells) for each
chemical and test system. Mean intralaboratory CVs for each test chemical averaged 18.9% for hepatocytes and 14.1% for S9
fractions, whereas interlaboratory CVs (all chemicals and all tests) averaged 30.1% for hepatocytes and 22.4% for S9 fractions.
When CLIN VITRO, INT values were extrapolated to in vivo intrinsic clearance estimates (CLIN VIVO, INT; l/d/kg fish), both assays
yielded similar levels of activity (<4-fold difference for all chemicals). Hepatic clearance rates (CLH; l/d/kg fish) calculated using
data from both assays exhibited even better agreement. These findings show that both assays are highly reliable and suggest
that either may be used to inform chemical bioaccumulation assessments for fish. This study highlights several issues related
to the demonstration of assay reliability and may provide a template for evaluating other in vitro biotransformation assays.
Key words: biotransformation; ring trial; in vitro intrinsic clearance; S9 fractions; hepatocytes; rainbow trout.
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Hydrophobic organic chemicals released to the environment
may accumulate in fish and other aquatic organisms. In gen-
eral, this behavior reflects the tendency of such chemicals to
partition out of water and into tissue lipids. Other chemicals ac-
cumulate in fish because of their affinity for specific proteins in
blood and tissues. In either case, this accumulation increases
the organism’s exposure to the chemical, increasing the risk of
adverse effects. For this reason, the potential for chemical bio-
accumulation in fish is commonly evaluated when performing
chemical hazard assessments, and limits on acceptable levels
of accumulation have been prescribed under several legislative
frameworks (Gobas et al., 2009).
The potential for a chemical to accumulate in fish may be
evaluated using standardized in vivo test methods (eg, OECD
Test Guideline 305; OECD, 2012), but these methods are expen-
sive, time-consuming, and require a large number of animals.
More commonly, bioaccumulation assessments are performed
using predictive computational models. One-compartment
mass-balance models, such as those given by Arnot and Gobas
(2003, 2004), are preferred for most screening-level assessments.
Physiologically based toxicokinetic (PBTK) models have also
been promoted as tools for bioaccumulation assessment
(Brinkman et al., 2016; Stadnicka et al., 2012). Because they de-
scribe chemical accumulation in specific tissues and organs,
PBTK models are well suited for relating in vitro effect concen-
trations to environmental exposures that would result in com-
parable in vivo chemical concentrations (“reverse
toxicokinetics”; Wetmore et al., 2012).
A critical input to both model types is the rate of hepatic bio-
transformation. Researchers have long known that biotransfor-
mation may reduce the extent of chemical accumulation in fish
(de Wolf et al., 1992; Oliver and Niimi, 1985; Southworth et al.,
1980). However, unlike most other inputs to the models (eg,
rates of chemical flux across the gills), the rate of biotransfor-
mation cannot be predicted with any confidence from chemical
hydrophobicity (eg, log KOW). For this reason, biotransformation
represents the principal source of uncertainty in many bioaccu-
mulation assessments for fish (Nichols et al., 2009).
In order to improve in silico predictions of chemical bioaccu-
mulation in fish, methods are needed to estimate hepatic bio-
transformation and incorporate this information into
established computational models. One promising approach
involves the measurement of intrinsic clearance using in vitro
metabolizing systems derived from liver tissue (Nichols et al.,
2006). This approach is based on methods pioneered by the
pharmaceutical industry for preclinical screening of drug candi-
dates (Rodrigues, 1997), and involves the measurement of bio-
transformation under nonsaturating conditions. The estimated
rate of intrinsic clearance may be used directly as an input to
PBTK models for fish (in the mass-balance equation for liver tis-
sue). Alternatively, this value may be extrapolated to the whole
animal to calculate a first-order metabolism rate constant (kM),
which is used as an input to one-compartment bioaccumulation
models. Several research groups have shown that incorporating
in vitro metabolism data into one-compartment models for fish
substantially improves model performance; that is, predicted
levels of accumulation are much closer to measured values
than predictions obtained assuming no metabolism (Cowan-
Ellsberry et al., 2008; Dyer et al., 2008; Gomez et al., 2010; Han
et al., 2007, 2009; Laue et al., 2014).
The use of in vitro data in a regulatory setting requires, how-
ever, that the methods used to generate this information are
shown to be reliable. In this context, the term “reliability” refers
to both repeatability (the ability of one user to generate the
same result) and reproducibility (the ability of multiple users to
obtain the same result). With regard to in vitro measurement of
biotransformation, additional questions relate to the utility of
different metabolizing systems and the need to account for dif-
ferences in activity of starting material. Here we describe the
results of an international ring trial involving 6 laboratories,
each of which evaluated 6 test chemicals using two in vitro me-
tabolizing systems: cryopreserved trout hepatocytes (RT-HEP)
and trout liver S9 fractions (RT-S9). The ring trial was conducted
with the goal of assessing intralaboratory variability (repeatabil-
ity) and interlaboratory variability (reproducibility) in assay per-
formance. Measured in vitro intrinsic clearance rates were then
extrapolated to common units of in vivo intrinsic clearance (l/d/
kg fish) to permit direct comparisons between the two assay
systems and provide a basis for predicting chemical-specific
bioconcentration factors (BCFs). The BCF is defined as the
steady-state chemical concentration in a fish divided by that in
water, assuming a water-only exposure, and is a well-known
metric of chemical bioaccumulation that is used extensively for
regulation of environmental contaminants (Gobas et al., 2009).
MATERIALS ANDMETHODS
Test chemical selection. The test chemicals cyclohexyl salicylate
(CS), fenthion (FEN), 4-n-nonylphenol (4NP), deltamethrin (DM),
methoxychlor (MC), and pyrene (PYR) were selected based on
their relative hydrophobicity, ease of analysis, and the existence
of measured bioaccumulation data for fish. Table 1 presents the
structure and measured log KOW value for each chemical,
whereas Table 2 presents measured and modeled BCFs.
Predicted BCFs were obtained using an established model
(Arnot and Gobas, 2003; as implemented within the in vitro–
in vivo extrapolation model given by Nichols et al., 2013b). The
BCFs given in column 3 were generated under the assumption
of no metabolism, and reflect the extent of chemical accumula-
tion predicted from simple partitioning considerations. Absent
biotransformation, each chemical would be expected to accu-
mulate substantially in fish (BCFs ranging from about 600 to
23 000). Generally, however, measured BCFs are considerably
lower than modeled values. All test chemicals except DM have
been evaluated previously using in vitro assays derived from
trout liver, thereby providing an opportunity to compare mea-
sured rates of activity to published values.
Chemicals and supplies. CS was provided by Givaudan Schweiz
AG. FEN, 4NP, DM, MC, and PYR were obtained from Sigma-
Aldrich (St. Louis, MO), as were the internal standards anthra-
cene (ANT), 4-n-nonylphenol-2,3,5,6-d4 (4NP-d4), methyl lau-
rate (ML), and permethrin (PM). Fenthion-d6 (FEN-d6) and
methoxylchor-d6 (MC-d6) were purchased from C/D/N
Isotopes (Pointe-Claire, Quebec, Canada). With the exception
of CS, all laboratories ordered test chemicals from the same
commercial lots. Additional information pertaining to test
chemicals and internal standards is provided in
Supplementary Table 1. Dulbecco’s modified Eagle’s medium
(low glucose) and Leibovitz-15 (L-15) medium were purchased
from Life Technologies (Carlsbad, CA). b-Nicotinamide ade-
nine dinucleotide phosphate was supplied by Oriental Yeast
Co. (Osaka, Japan) or Enzo Life Sciences (Exeter, UK).
Adenosine 30-phosphate 50-phosphosulfate lithium salt was
purchased from Sigma-Aldrich or EMD Millipore (Temecula,
CA). Reduced L-glutathione was obtained from Sigma-Aldrich
or Thermo Fisher Scientific (ACROS Organics; Geel, Belgium).
Uridine 50-diphosphoglucuronic acid trisodium salt,
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Table 1. Test Chemicals Used to Evaluate the Reliability of In Vitro Substrate Depletion Assays
Chemical Structure Log KOW Previous Use in In Vitro
Studies With RT-HEP
and RT-S9
Cyclohexyl salicylate 4.70a Laue et al. (2014)
Fenthion 4.09b Fay et al. (2014b)
4-n-Nonylphenol 5.76b Mingoia et al. (2010) Han
et al. (2007, 2008, 2009)
Fay et al. (2014b)
Deltamethrin 6.20b Not tested
Methoxychlor 5.08b Fay et al. (2014b)Bischof
et al. (2016)
Pyrene 4.88b Fay et al. (2014a, 2017)
Mingoia et al. (2010)
Nichols et al. (2013a,b,
2017)
aMeasured value given by Laue et al. (2014).
bMeasured values from the U.S. EPA EPI Suite experimental database (U.S. EPA, 2012).
Abbreviations: RT-HEP, cryopreserved rainbow trout hepatocytes; RT-S9, rainbow trout liver S9 fractions.
Table 2. Comparison of Measured and Modeled Chemical Bioconcentration Factors (BCFs; l/kg)
Chemical Measured In
Vivo BCFsa
(From Literature)
BCF Model
Predictions Assuming
No Biotransformationb
BCF Model Predictions Obtained
Using In Vitro Rates of Biotransformation (RT-HEP and RT-S9)b,c
RT-HEP
fU¼ fU, P/fU, HEP
RT-HEP
fU¼ 1.0
RT-S9
fU¼ fU, P/fU, S9
RT-S9
fU¼ 1.0
Cyclohexyl salicylate 400d 2371 217611 18161 448650 18161
Fenthion 182e 607 277643 11762 192619 11361
4-n-Nonylphenol 290f 16 549 29096676 321614 38916590 381622
Deltamethrin 115g 22 900 407061259 311629 22756359 286610
Methoxychlor 174h 5229 38356398 446684 33596113 423618
Pyreneh 78i 3490 709678 21362 316621 20461
aAdditional details on in vivo BCF studies are included in OECD Project 3.13 Study Report, Annex 10 (OECD, 2017).
bGenerated using models given by Nichols et al. (2013b). The models were run assuming a 10 g fish containing 5% lipid, exposed at 12C.
cFor all chemicals except PYR, reported BCFs represent the interlaboratory mean6SD (n¼6). Interlaboratory means were based on intralaboratory means for each labo-
ratory. Intralaboratory means were based in turn on in vitro datasets for 3 independent runs. For PYR, BCFs represent the mean6SD of all interlaboratory means (n¼5),
where PYR was run in parallel with a given test chemical.
dAverage of two measured steady state values for zebrafish (RIFM study); cited in Laue et al. (2014).
eAverage of 36 studies/measurements for medaka, guppies, goldfish, and minnows (Tsuda et al., 1993, 1995, 1996, 1997).
fAverage of 6 measurements for fathead minnows (Giesy et al., 2000; Snyder et al., 2001).
gModeled value for rainbow trout based on measured parent chemical concentrations at the lowest dissolved organic carbon concentration (Muir et al., 1994).
hMeasured 140 d value for sheepshead minnows (Hansen and Parrish, 1977).
iAverage of 4 measured 36 d values for sheepshead minnows (Jonsson et al., 2004).
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alamethicin, and all other reagents and solvents were
obtained from Sigma-Aldrich.
Animals. Rainbow trout (Oncorhynchus mykiss) were obtained
from the USGS Upper Midwest Environmental Sciences Center
(La Crosse, WI). The fish were fed a commercial trout chow
(Classic trout; Skretting, Tooele, UT) and maintained at 1161C
under a 16:8-h light:dark cycle. Water used for fish holding was
obtained directly from Lake Superior (single-pass, sand-filtered,
and UV-treated) and had the following characteristics: alkalinity
43–47 mg/l as CaCO3, pH 7.2–7.8, and dissolved O2 85%–100% of
saturation. All trout holding conditions and experimental pro-
cedures were approved by an Institutional Animal Care and Use
Committee in accordance with principles established by the
Interagency Research Animal Committee.
The mean weight of fish sampled to obtain isolated hepato-
cytes was 395.5683.4 g, whereas that of fish used to obtain liver
S9 fractions was 322.96 42.0 g. The sexual maturity of each ani-
mal was evaluated by determining its gonadosomatic index
(GSI; mass of gonads/total body mass 100). Measured GSI val-
ues suggested that all fish were in very early stages of sexual
maturation (Gomez et al., 1999; Le Gac et al., 2001).
Preparation and characterization of cryopreserved trout hepatocytes
and trout liver S9 fractions. RT-HEP and RT-S9 were generated in
one location (U.S. Environmental Protection Agency, Mid-
Continent Ecology Division, Duluth) and shipped to the other
participating laboratories. All donor fish were drawn from the
same mixed sex population of animals. RT-HEP were obtained
using methods given by Fay et al. (2015). Each sample lot con-
tained cells from 7 animals. The fresh cells were suspended in
buffer containing dimethyl sulfoxide, aliquoted into 1.8 ml cryo-
genic sample vials, and transferred to the vapor phase of liquid
N2 for freezing and storage. RT-S9 were prepared as described
by Johanning et al. (2012a). Sample lots used to measure in vitro
enzyme activity contained S9 fractions from 3 (CS, 4NP, FEN,
and DM) or 6 (MC) fish. An additional sample lot, obtained using
pooled material from 4 fish, was prepared for use as enzymati-
cally inactive control material. Individual sample lots were ali-
quoted (150 ml) into 0.5 ml reaction tubes, frozen by immersion
in liquid N2 and stored at –80C. RT-HEP and RT-S9 were shipped
together in the vapor phase of liquid N2.
RT-HEP and RT-S9 from each sample lot were characterized
using model substrates for CYP1A, uridine diphosphate glucuro-
nosyltransferase (UGT), and glutathione-S-transferase (GST).
CYP1A plays a major role in biotransformation of hydrophobic
contaminants by fish (Schlenk et al., 2008), whereas glucuroni-
dation is thought to be the most important phase II conjugation
reaction (Clarke et al., 1991; James, 1986). CYP1A activity was de-
termined by measuring the rate of 7-ethoxyresorufin O-dealky-
lation (EROD assay). UGT activity was characterized by
measuring glucuronidation of p-nitrophenol. GST activity was
assessed by measuring glutathione conjugation of 1-chloro-2,4-
dinitrobenzene. Characterization assays run using RT-HEP were
performed on cell lysates as described by Fay et al. (2014a),
whereas RT-S9 were characterized using methods given by
Nichols et al. (2013a). The protein content of cell lysates and RT-
S9 were determined using Peterson’s modification of the Lowry
method (Sigma technical bulletin TP0300; Sigma-Aldrich). All
characterization assays were performed on thawed material at
the laboratory of origin.
Hepatocyte yield and viability. Thawed hepatocytes were evalu-
ated in the presence of 0.04% trypan blue to determine cell yield
and viability (Fay et al., 2015). These suspensions were then di-
luted to the desired concentration of viable cells (1 or
2 106 cells/ml) in L-15 and recounted for accuracy.
Preparation of enzymatically inactive material. Hepatocyte suspen-
sions (2 106 cells/ml in L-15 medium) and S9 fractions
(25 mg/ml protein in 100 mM potassium phosphate buffer)
were inactivated by boiling for 15 min in a 100C water bath. For
hepatocyte suspensions, the final volume was adjusted by addi-
tion of L-15 to maintain the concentration of enzymatically in-
active material. For the S9 material, the final volume was
adjusted with phosphate buffer to twice the original volume.
The sample was then homogenized with a mortar and pestle so
that it could be pipetted into cryogenic sample vials for freezing
and storage. All heat-inactivated samples were prepared in ad-
vance in one location (U.S. EPA, MED, Duluth) and stored at –
80C before shipping to the other participating laboratories.
Experimental design. The study design was informed by a statisti-
cal analysis of two previous multi-laboratory studies conducted
using RT-HEP (Fay et al., 2014b) and RT-S9 (Johanning et al.,
2012b). An analysis of these findings was performed using a
linear-mixed effects (LMEs) model (McCulloch et al., 2008) to de-
termine which factors contributed the most to variability in
measured rates of biotransformation. The LME model was fit
with restricted maximum likelihood to model intrinsic clear-
ance as a population parameter, chemical and sampling time
point as fixed effects, and laboratory, run (number of indepen-
dent assays) and replicate vial (number of vials per time point)
as random effects. Likelihood-ratio tests (LRTs; Graybill, 1976)
were then performed to determine whether the contribution of
a variance component to overall variability in the data was sta-
tistically significant (p< .05). The LRT analysis showed that the
contribution of replicate vial effects to overall variability was
not significant. In contrast, the contribution of run effects was
not significant for active hepatocytes, but was significant for en-
zymatically inactive hepatocytes, and for both active and heat-
inactivated S9 fractions. A detailed description of these analysis
methods and subsequent findings is provided in the OECD
Project 3.13 Study Report, Annex 4 (OECD, 2017).
The final study design involved 6 laboratories (A–F) located
in Europe (2) and the United States (4). This group included 4 in-
dustry laboratories, an academic laboratory, and a private re-
search institute. A separate government laboratory provided
the biological material as well as analytical support. Each of the
laboratories A–F evaluated 6 chemicals (CS, FEN, 4NP, DM, MC,
and PYR) using both RT-HEP and RT-S9. Assays performed using
CS, FEN, 4NP, DM, and MC were conducted with specific lots of
biological material. PYR, employed as an internal reference
chemical, was run in parallel with each of the other 5 test chem-
icals to obtain a dataset covering all lots of biological material.
Three runs, conducted on different days, were performed for
each test chemical and biological matrix. Each run was per-
formed using a single reaction vial (one replicate), with one sub-
sample withdrawn at each of 7 sampling time points.
Substrate depletion assays. In vitro intrinsic clearance rates were
measured using a substrate depletion approach (Fay et al., 2015;
Johanning et al., 2012a). Brief descriptions of each assay are pro-
vided as Supplementary Data (In vitro methods). Preliminary
assays were conducted to evaluate the substrate concentration-
dependence of activity, assess the kinetics of depletion, and op-
timize the sampling schedule. This information was then used
to identify the lowest starting substrate concentration that
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would yield high quality measurements across most or all of
the sampling times, taking into consideration the rate of activ-
ity and the analytical method limit of detection. Additional pre-
liminary studies were conducted to determine stopping
conditions (solvent type and ratio of sample to solvent), opti-
mize extraction procedures, and ensure that there were no ana-
lytical interferences. The final reaction conditions for each test
chemical are described in Supplementary Table 2.
Chemical analyses. Samples containing CS and MC were analyzed
by gas chromatography/mass spectrometry (GC/MS). DM was
analyzed by GC with tandem mass spectrometry, FEN and 4NP
were analyzed by liquid chromatography with tandem mass
spectrometry, and PYR was analyzed by high performance liq-
uid chromatography with fluorescence detection. All samples
generated for each test chemical were shipped to one laboratory
for analysis. The purpose of this approach was to limit analyti-
cal variability as a contributing factor when making interlabora-
tory comparisons. Details pertaining to methods,
instrumentation, and the laboratory responsible for analysis of
test and reference chemicals are provided as Supplementary
Data (Analytical methods).
Determination of in vitro intrinsic clearance. Measured chemical
concentrations were log10-transformed and plotted against time
to determine a first-order elimination rate constant (k; 1/h,
equal to –2.3 slope). Rate constants determined in the S9 assay
were divided by protein concentration (mg/ml) to calculate
in vitro intrinsic clearance (CLIN VITRO, INT; ml/h/mg protein). For
the hepatocyte assay, CLIN VITRO, INT (ml/h/10
6 cells) was deter-
mined by dividing k by the measured concentration of viable
cells.
Analysis of in vitro intrinsic clearance data. Intra- and interlabora-
tory variability were characterized as the percent coefficient of
variation (CV; equal to the standard deviation/mean 100%) in
measured values. Intralaboratory variability in yield and viabil-
ity of RT-HEP was calculated from a laboratory’s daily averages
for each cell lot. Interlaboratory variability in these measure-
ments was then calculated for each cell lot from overall aver-
ages determined by each laboratory. Intralaboratory variability
in CLIN VITRO, INT was calculated from values determined for 3 in-
dependent runs. Interlaboratory variability in CLIN VITRO, INT was
calculated from overall averages determined by each laboratory
for each test chemical. CVs calculated using RT-HEP and RT-S9
data were compared using a Wilcoxon sum-rank (also known as
a Mann–Whitney U) test. A p-value< .05 was considered to be
statistically significant.
The potential for laboratory bias in CLIN VITRO, INT measure-
ments was evaluated by ranking average values determined by
each laboratory for CS, FEN, 4NP, DM, and MC from 1 to 6 (low to
high). Additional ranks were obtained for PYR, which was evalu-
ated in parallel with the other 5 test chemicals. The rank data
for each in vitro test system were then evaluated using
Friedman’s test (a nonparametric equivalent of an ANOVA ap-
plicable to complete block designs) with laboratory as the treat-
ment effect blocked on each chemical tested. Every PYR test
was treated as a different block. Because one laboratory did not
test PYR in parallel with MC, PYR data collected during the MC
studies was omitted from the analysis, giving 9 chemical blocks
in total. Pairwise comparisons of laboratory rank were per-
formed a posteriori using Conover’s test with Bonferroni-Holm
adjusted p-values.
A second analysis using the Kendall rank correlation test
was performed to test whether the rank determined for a given
test chemical was correlated with the rank determined for PYR,
run in parallel with the same chemical. Due to the lack of a
complete PYR dataset, the MC studies were excluded from this
analysis. This resulted in 4 comparisons (one each for CS, FEN,
4NP, and DM) per laboratory.
Clearance rate comparisons among in vitro test systems. To provide
a direct basis for comparing the two in vitro test systems, CLIN
VITRO, INT values determined using each system were extrapo-
lated to common units of in vivo intrinsic clearance (CLIN VIVO,
INT; l/d/kg fish). Scaling factors used to perform these extrapola-
tions (163 mg S9 protein/g liver and 510 106 hepatocytes/g
liver) were based on earlier work with sexually immature trout
of the same age, source, and strain (Fay et al., 2014a; Nichols
et al., 2013b). Liver size as a fraction of total body weight was set
equal to the value (0.015) determined by Schultz and Hayton
(1999) for small trout typical of those used in bioconcentration
testing efforts.
CLIN VIVO, INT values calculated for CS, FEN, 4NP, DM, and MC,
using data from both in vitro test systems, were compared using
a two-way ANOVA, applying a Bonferroni–Holm adjustment to
a posteriori intrachemical comparisons. Due to the large range of
calculated values, a log10 transformation was applied prior to
the analysis. Because PYR was employed in the study in a
unique manner, direct comparisons between the two in vitro
test systems for this chemical were made independently using
a standard unpaired t-test.
CLIN VIVO, INT values calculated for each chemical and test
system were then used as inputs to a well-stirred liver model to
obtain a set of hepatic clearance estimates (CLH; l/d/kg fish)
(Rowland et al., 1973; Wilkinson and Shand, 1975).
CLH ¼ QHfUCLIN VIVO;INTQH þ fUCLIN VIVO;INT
In this model, QH (l/d/kg fish) is liver blood flow rate and fU
(unitless) is a binding term used to correct for binding effects
in vitro and in blood plasma. For this evaluation, QH was calcu-
lated as 0.259 times the estimated cardiac output in small (10 g)
trout commonly employed for standardized bioconcentration
testing (Nichols et al., 2013b). Initially, the binding term fU was
calculated as the ratio of unbound chemical fractions in blood
plasma (fU,P) and in the in vitro test system (fU,HEP or fU,S9)
(“restricted clearance”). Empirically based algorithms used to
estimate these binding terms are described by Nichols et al.
(2013a) and Fay et al. (2017). A second analysis was then per-
formed by setting fU equal to 1.0 (“unrestricted clearance”). This
approach assumes that chemical bioavailability to metabolizing
enzymes in vitro and in vivo is effectively the same.
Prediction of chemical BCFs. Finally, CLIN VITRO, INT values deter-
mined using both in vitro test systems were used as inputs to
two spreadsheet models (RT-HEP and RT-S9) that predict bio-
transformation impacts on chemical bioconcentration in trout
(Nichols et al., 2013b). These models perform the in vitro–in vivo
extrapolation described above to predict CLH. The CLH estimate
is then extrapolated to a first-order whole-body elimination
rate constant (kM; 1/d) which is used as an input to a one-
compartment bioconcentration model (Arnot and Gobas, 2003).
The spreadsheet models are designed to predict BCF values for
juvenile rainbow trout (10 g, 5% lipid content, tested at 12C)
typically used in standardized in vivo testing efforts (OECD,
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2012). Additional rate constants that describe chemical uptake
across the gills, elimination across the gills, and egestion in fe-
ces are calculated from chemical log KOW using empirically
based relationships. Details pertaining to the development of
these relationships are provided elsewhere (Arnot and Gobas,
2003). BCFs predicted using in vitro data were then compared
with BCFs measured previously in controlled laboratory expo-
sures as well as modeled BCFs predicted under the assumption
of no biotransformation.
RESULTS
Characterization of Cryopreserved Hepatocytes and Liver S9
Fractions
EROD, UGT, and GST activities for individual lots of RT-HEP av-
eraged 5.4361.20 pmol/min/mg protein, 2256 19 pmol/min/mg
protein, and 425632 nmol/min/mg protein, respectively
(Supplementary Table 3). In each case, these are basal rates of
activity measured under saturating substrate conditions. As
such, the data can be used to assess variability in Vmax values
for each reaction pathway among the pooled cell lots. A similar
evaluation of RT-S9 samples yielded means of 5.4960.44 pmol/
min/mg protein, 11786109 pmol/min/mg protein, and
8896 159 nmol/min/mg protein, respectively. All measured
rates are within 50% of values determined previously for RT-
HEP and RT-S9, obtained from trout of the same strain. For ex-
ample, Fay et al. (2017) reported EROD, UGT, and GST activities
of 6.262.2 pmol/min/mg protein, 309666 pmol/min/mg
protein, and 260644 nmol/min/mg protein, respectively, for
RT-HEP. Measured activities reported previously for RT-S9
(both sexes) averaged 7.4960.46 pmol/min/mg protein,
7696 106 pmol/min/mg protein, and 497628 nmol/min/mg pro-
tein, respectively (Nichols et al., 2013a).
Yield and Viability of Thawed Hepatocytes
Averaged across all 6 laboratories, the yield for each cell lot
ranged from 28.1% to 35.3%, whereas cell viability ranged from
85.5% to 87.2% (Supplementary Table 4). The intralaboratory
variability in replicated cell yield determinations ranged from
2.1% to 37.7%. Intralaboratory variability in cell viability meas-
urements ranged from 0.2% to 5.8%. For each corresponding cell
lot and testing laboratory, the variability in cell yield was greater
than that for cell viability (n¼ 30). The interlaboratory variability
in cell yield for each cell lot was relatively large, resulting in CVs
that ranged from 14.4% to 40.7%. The interlaboratory variability
in cell viability measurements ranged from 4.6% to 6.5%.
In Vitro Intrinsic Clearance
Figure 1 shows the complete set of depletion data for FEN, gen-
erated using both RT-HEP and RT-S9. Qualitatively similar
results were obtained for the other 5 test chemicals
(Supplementary Figs. 1–4). The data for active samples generally
exhibited the expected log-linear decrease in chemical concentra-
tion, and in each case the slope derived from the fitted linear re-
gression was significantly different from 0. A close examination of
Figure 1 suggests, however, that there was a slow rate of chemical
depletion from heat-inactivated S9 controls. Similar results were
obtained in S9 assays performed using CS and DM. In contrast,
there was little or no indication of chemical depletion from heat-
inactivated hepatocytes for any of the test chemicals.
Follow-up studies were conducted with all test chemicals to
determine whether the apparent loss from heat-inactivated S9
samples was real or an artifact. For this effort, S9 samples from
the same experimental lot were inactivated by allowing sam-
ples to stand at room temperature overnight (benchtop
method). The reactions were then run in the absence of added
cofactors. In all but one case (4NP), depletion rates for samples
treated in this manner were statistically indistinguishable from
0. For 4NP, optimal results (ie, no significant depletion) were
obtained using heat-inactivated samples; nevertheless, the loss
from samples inactivated by time and the omission of cofactors
was negligible. It is unlikely, therefore, that the apparent loss of
chemical from heat-inactivated S9 samples reflected a true loss
of chemical from the system. Based on these findings, CLIN
VITRO, INT values for all chemicals and both test systems were
calculated using measured rates of depletion from active sam-
ples without additional correction.
The rank order of CLIN VITRO, INT determined using RT-HEP
was: CS> FEN> 4NP>DM>MC, whereas that determined using
RT-S9 was: CS> FEN>DM> 4NP>MC (Figs. 2 and 3). For the
hepatocytes, clearance rates averaged for each chemical across
all 6 laboratories ranged from 0.08 ml/h/106 cells to 10.80 ml/h/
106 cells, a 135-fold difference. The range of measured activities
was somewhat lower for RT-S9 (0.32 ml/h/mg protein to
21.50 ml/h/mg protein, a 67-fold difference). Measured CLIN
VITRO, INT values and associated CVs for each test system are
summarized in Supplementary Tables 5 and 6. For clarity, intra-
laboratory CVs determined by one laboratory for a single chemi-
cal are referred to as “lab-specific” values, whereas
intralaboratory CVs averaged across all 6 laboratories for a sin-
gle chemical (appearing under the column heading “Mean CV
(%)”) are termed “chemical specific” values. Chemical-specific
intralaboratory CVs that were calculated from activities mea-
sured using RT-HEP were generally similar, ranging from 16.3%
to 22.7%. The range of chemical-specific intralaboratory CVs de-
termined using RT-S9 data (4.8% to 28.7%) was somewhat larger;
however, this finding was largely driven by three unusually
high lab-specific values for one chemical (DM). The mean of all
5 chemical-specific intralaboratory CVs calculated for RT-HEP
(18.6%6 3.0%) was greater than that determined for RT-S9
(14.1%6 8.9%), but this difference was not significant (p¼ .151).
Interlaboratory CVs developed using RT-HEP data (mean, across
all chemicals¼ 32.4%64.1%) were significantly larger (p¼ .012)
than those generated using data from RT-S9 (mean, across all
chemicals¼ 17.7%66.8%). In every case, the chemical-specific
intralaboratory CV calculated for a given chemical and test sys-
tem was smaller than the corresponding interlaboratory CV.
The lowest calculated interlaboratory CV (9.4%) was associated
with metabolism of MC by RT-S9. As noted above, MC was the
most slowly metabolized of all test chemicals in both systems.
Overall, however, there were no clear trends for either test sys-
tem regarding interlaboratory CVs and the rank order of chemi-
cal clearance.
Use of PYR as a Reference Chemical
Substrate depletion assays employing PYR as a reference chem-
ical were performed in parallel with those conducted for the
other 5 test chemicals. As indicated previously, these 5 chemi-
cals were evaluated using different lots of biological material.
The results for PYR therefore provided an opportunity to evalu-
ate lot-to-lot differences in metabolic activity, as well as differ-
ences between the in vitro assays themselves (Supplementary
Figs. 5–9 and Supplementary Table 7). CLIN VITRO, INT values for
the 5 cell lots varied by a factor of 1.61 (highest/lowest, based on
averages calculated across all laboratories), and by a factor of
1.66 for the 5 lots of RT-S9. These lot-to-lot differences in activ-
ity were significant for RT-HEP (one-way ANOVA; p¼ .046), but
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not for RT-S9 (p¼ .062). The mean of lab-specific intralaboratory
CVs determined for each lot of RT-HEP (19.2%6 4.0%) was
greater than that calculated using data from RT-S9
(14.1%6 2.6%), but this difference was not significant (p¼ .061).
Averaged across all 5 cells lots, the mean interlaboratory CV for
PYR (27.9%611.0%) was essentially identical to that
(27.0%6 14.0%) determined for the 5 lots of RT-S9.
Assessment of Possible Study Bias
A rank-order assessment was performed on measured CLIN
VITRO, INT values to test for possible laboratory bias in study find-
ings. The objective of this analysis was to determine whether
there were any trends with respect to absolute rates of mea-
sured activity, as would be evidenced (for example) by one labo-
ratory reporting the highest (or lowest) values for most or all
test chemicals. This assessment was performed by combining
rank order data for all 6 test chemicals. For the hepatocytes,
there was a significant difference in ranks associated with indi-
vidual laboratories (Friedman’s test; p¼ .002). A plot of these
ranks suggested a trend across all 6 laboratories (Figure 4A).
However, a post hoc analysis did not confirm this (Conover’s
test with Bonferroni–Holm adjusted p-values). Instead, these
pairwise comparisons showed only that laboratory B was differ-
ent from laboratories A, C, and F, and that laboratory D was dif-
ferent from laboratory A (Supplementary Table 8). A similar
analysis of ranks for the RT-S9 data also indicated a significant
difference among laboratories (p¼ .006; Figure 4B). In this case,
pairwise comparisons showed that laboratory F was different
from laboratories A, B, and C, whereas laboratory D was differ-
ent from laboratories A and B (Supplementary Table 8).
Figure 1. In vitro biotransformation of fenthion (FEN) by rainbow trout liver S9 fractions (RT-S9) and cryopreserved rainbow trout hepatocytes (RT-HEP). Each panel
shows data from one laboratory. Different symbol shapes represent measured concentrations from 3 independent experiments performed on different days. Filled
symbols represent data derived from active biological material, whereas open symbols represent data from enzymatically inactive controls. Depletion curves shown
for the RT-HEP assays do not take into account small differences in cell concentration between runs (typically6 25% of nominal). Lines shown in each panel represent
linear regression equations fitted to the data from independent runs.
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A second analysis was performed to compare laboratory
ranks for each test chemical with the laboratory ranks for PYR,
in the restricted case where PYR was run alongside the same
chemical. At issue was the question of whether paired depletion
experiments performed using a reference chemical (PYR) would
prove useful in identifying laboratory bias. Rank-rank plots pro-
vide a graphical representation of these findings (Figure 5). Each
observation represents a rank-rank pairing for one laboratory.
If, for example, one laboratory obtained the highest clearance
rate for both CS and PYR run in parallel with CS, this pairing
would be represented as one observation (6/6) in the upper right
hand corner of the plot. Perfect correspondence between the
rank pairs would result in 6 points (n¼ 4 occurrences each) run-
ning diagonally from the lower left corner to the upper right
corner.
The rank-rank plot developed using data from RT-HEP pro-
vides graphical evidence for a weak correlation between mea-
sured clearance rates for individual test chemicals and for PYR
(Figure 5A). This was confirmed by the Kendall rank correlation
test result which, though significant (p¼ .025), was only margin-
ally so. In contrast, the rank-rank plot obtained using data from
RT-S9 provided no evidence for a correlation (Figure 5B). The
correlation test result (p¼ .183) was consistent with this finding.
Clearance Rate Comparisons Among In Vitro Test Systems
Measured rates of CLIN VITRO, INT determined using RT-HEP and
RT-S9 were extrapolated to common units of CLIN VIVO, INT (l/d/kg
fish) to permit direct comparisons between the two in vitro test
systems (Figure 6). For PYR, these comparisons were based on
CLIN VITRO, INT values determined for all lots of biological material
(RT-HEP or RT-S9). For the other test chemicals, mean CLIN VIVO,
INT values represent activity measured using a single lot of RT-
HEP or RT-S9. With the exception of PYR, the resulting CLIN VIVO,
INT values for each chemical differed by no more than a factor of
3. The average CLIN VIVO, INT value for PYR determined using RT-
S9 was 3.9 times greater than that determined using RT-HEP.
A subsequent analysis of test data for CS, FEN, 4NP, and DM
(two-way ANOVA using Bonferroni-Holm adjusted p-values for
intrachemical comparisons) indicated that there were no trends
in the data which would suggest that one in vitro test system or
the other consistently yields a higher or lower rate of activity
(p¼ .77). For 4NP, however, CLIN VIVO, INT values determined
Figure 2. In vitro intrinsic clearance rates (CLIN VITRO, INT) for methoxychlor (MC),
deltamethrin (DM), 4-nonylphenol (4NP), fenthion(FEN), and cyclohexyl salicy-
late (CS), determined using cryopreserved rainbow trout hepatocytes (RT-HEP).
The symbols represent intrinsic clearance rates measured by 6 different labora-
tories (A–F). Each symbol represents the mean of 3 independently determined
values. Variances associated with each of these means are given in
Supplementary Table S5.
Figure 3. In vitro intrinsic clearance rates (CLIN VITRO, INT) for MC, 4NP, DM, FEN,
and CS, determined using rainbow trout liver S9 fractions (RT-S9). The symbols
represent intrinsic clearance rates measured by 6 different laboratories (A–F).
Each symbol represents the mean of 3 independently determined values.
Variances associated with each of these means are given in Supplementary
Table S6.
Figure 4. Evaluation of potential laboratory bias in measured in vitro intrinsic clear-
ance rates (CLIN VITRO, INT). Individual laboratories are identified as A–F. The median
rank associated with each laboratory is shown as a horizontal thick line, and the
top and bottom of each box represents the 75th and 25th percentiles, respectively.
The top and bottom whiskers extend up to 1.5 times the interquartile range,
whereas dots represent individual observations beyond this range. Calculated
ranks are based on measured rates of activity for CS, FEN, 4NP, DM, and MC (one
value for each laboratory). Additional ranks were calculated using data for pyrene
(PYR; 4 independent determinations per laboratory), run as a reference chemical
(n¼ 9 total ranks). A, Ranks determined for each laboratory based on data collected
using cryopreserved rainbow trout hepatocytes (RT-HEP). B, Ranks determined for
each laboratory based data collected using rainbow trout liver S9 fractions (RT-S9).
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using RT-HEP were significantly higher than those obtained us-
ing RT-S9 (p¼ .021), whereas in the case of FEN the opposite was
true (p¼ .026). For PYR, CLIN VIVO, INT rates obtained using RT-S9
were significantly higher than those determined using RT-HEP
(t-test; p< .001).
Under the restricted clearance assumption, CLH values pre-
dicted for each chemical using data from the two in vitro test sys-
tems differed by less than a factor of 2.6 (Figure 7). This improved
agreement, relative to that for calculated CLIN VIVO, INT values, can
be attributed to the fact that for several chemicals the product
term fu CLIN VIVO, INT was approaching the estimated rate of liver
blood flow (ie, the theoretical maximum value), which is shown
in the figure as a dashed line. The observed agreement between
CLH values predicted using both test systems was even greater
when using the unrestricted clearance assumption.
Prediction of Chemical BCFs
For each of the test chemicals, BCFs predicted using in vitro data
were much closer to previously measured values than were
BCFs predicted under the assumption of no biotransformation
(Table 2). Generally, however, the best correspondence between
measured and modeled BCFs was achieved when using the
unrestricted clearance assumption (fU¼ 1.0), particularly for
chemicals with higher log KOW values. Moreover, BCFs predicted
under this assumption using either test system (RT-HEP or
RT-S9) were nearly identical. This outcome follows from the
close agreement between predicted CLH values noted above.
DISCUSSION
In vitro assays have been used for decades to measure biotrans-
formation in a variety of organisms. However, apart from two
previous studies with RT-S9 and RT-HEP (Fay et al., 2014b;
Johanning et al., 2012b), we are unaware of any efforts to evalu-
ate the reliability of these methods across multiple laboratories.
Differences between the present study and earlier work include
the number of participating laboratories (6 vs. 3 or 4), use of
both RT-HEP and RT-S9 (not one or the other), and incorporation
of PYR as an internal reference compound. Whereas previous
studies were limited to a simple characterization of assay reli-
ability, as represented by the CV in replicated measurements,
the current study design permitted direct comparisons of the
two in vitro test systems, including the reliability of each
method and differences in predicted rates of in vivo intrinsic
clearance. The use of an internal reference compound provided
a means for characterizing lot-to-lot differences in activity of bi-
ological material. The larger number of laboratories and incor-
poration of a reference chemical also provided data needed to
perform a rigorous assessment of possible laboratory bias.
Measurable rates of substrate depletion were observed for all
6 test chemicals in both test systems. The CLIN VITRO, INT values
determined across individual test chemicals differed by 2
orders of magnitude. For MC, the most slowly metabolized of
the test chemicals, depletion rate constants averaged 0.16/h for
RT-HEP and 0.32/h for RT-S9. The working lifetime of these in vi-
tro preparations remains to be firmly established; however, de-
pletion rates in this range are close to the lower limit that can
be accurately quantified by these approaches. Previously, Chen
et al. (2016) suggested that this limit value was approximately
0.14/h for RT-S9, based on modeled simulations of hypothetical
depletion data. The actual limit value will vary depending on
the quality of a dataset and the behavior of enzymatically inac-
tive controls.
Figure 5. Rank-rank plots showing the relationship between intrinsic
clearance values for individual test chemicals and for PYR, where PYR
was run alongside the same test chemical. Each observation represents a
pair of ranks for one laboratory. The frequency of any given observation
(1–3 out of a possible 4) is denoted by the size of the dot. A, Ranks based
on data collected using cryopreserved rainbow trout hepatocytes (RT-
HEP). B, Ranks based on data collected using rainbow trout liver S9 frac-
tions (RT-S9).
Figure 6. Estimated in vivo intrinsic clearance rates (CLIN VIVO, INT) for MC, DM,
4NP, FEN, PYR, and CS. CLIN VIVO, INT values were calculated from measured
rates of in vitro intrinsic clearance obtained using cryopreserved rainbow trout
hepatocytes (RT-HEP) or trout liver S9 fractions (RT-S9). Means calculated for
all laboratories are shown as horizontal lines. Values shown for MC, DM, 4NP,
FEN, and CS represent data generated using chemical-specific lots of biologi-
cal material, whereas those given for PYR represent studies performed using
all 5 lots of tested material. Boxes denote the 25th and 75th percentiles,
whereas top and bottom whiskers extend up to 1.5 times the interquartile
range.
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For several of the chemicals evaluated in this effort, the use
of boiled RT-S9 as a negative control resulted in an apparent
loss of compound from the reaction system. However, when the
same chemicals were introduced to a test system inactivated
using the benchtop method there was no discernable loss of
compound. Deposition of heat-denatured protein onto the wall
of the reaction vessel with repeated vortexing may have re-
duced the amount of chemical remaining in solution.
Additional work is required to evaluate this possibility.
Presently, it appears that the benchtop method of inactivating
RT-S9 provides a simple and effective means of creating control
material. Boiling RT-HEP also results in a solution containing
denatured protein, but the character of this solution differs
from that of boiled RT-S9, perhaps due to a lower protein con-
tent (0.3 to 0.4 mg/mL for a solution containing 2 106 cells/ml;
Fay et al., 2017). As noted previously, there was no discernable
loss of chemicals from vials containing boiled RT-HEP.
In all but one case, CLIN VITRO, INT values measured in this
study for individual test chemicals were within a factor of 10 of
previously reported values (Supplementary Table 9). In general,
however, rates determined in the present study are higher than
those given earlier. For CS, these differences may be due to dif-
ferences in activity of starting biological material. Laue et al.
(2014) reported a CLIN VITRO, INT of 3.49 ml/h/mg protein for CS,
whereas the CLIN VITRO, INT determined in the present study was
22.64 ml/h/mg protein. The starting substrate concentration
(1lM) used in both studies was the same, but rainbow trout
used to provide liver S9 fractions were obtained from different
sources. In the case of FEN, differences in starting substrate
concentration may have played a role. Thus, Fay et al. (2014b)
reported a clearance rate 0.25 ml/h/106 cells for FEN at a starting
substrate concentration of 2 lM. In the present effort, the CLIN
VITRO, INT determined for FEN was 1.51 ml/h/10
6 cells, although
the starting substrate concentration was 0.2 lM. The CLIN VITRO,
INT determined in this study for PYR (3.48 ml/h/10
6 cells) is
nearly 100 times faster than that (0.036 ml/h/106 cells) reported
by Mingoia et al. (2010; mean of all values for RT-HEP). The start-
ing substrate concentration employed by Mingoia et al. (2010)
was 10 lM. This concentration is substantially higher than the
Michaelis–Menten affinity constant (KM) for PYR determined
using RT-S9 (0.070 lM; Nichols et al., 2017). It is likely, therefore,
that experiments conducted by Mingoia et al. (2010) were per-
formed under saturated conditions.
The reliability of each in vitro assay was assessed by quanti-
fying intra- and interlaboratory variability in repeated clearance
rate determinations. Chemical-specific intralaboratory CVs cal-
culated for all 6 test compounds averaged 18.9% for RT-HEP and
14.1% for RT-S9. A similar level of intralaboratory variability was
observed previously in a more limited ring trial conducted using
RT-HEP (mean CV, all chemicals¼ 17%; Fay et al., 2014b). In most
cases, intralaboratory CVs calculated for a given chemical and
test system were substantially smaller than the corresponding
interlaboratory CV. This finding was expected and reflects a
high level of consistency in the performance of both assays by
individual users.
Interlaboratory CVs calculated across all chemicals and tests
averaged 30.1% for RT-HEP and 22.4% for RT-S9. This apparent
difference in assay performance was probably due to increased
variability inherent to the use of cryopreserved cells. For the RT-
HEP assay, the user must reconstitute frozen samples through a
series of steps, count live cells, and dilute the sample accord-
ingly (Fay et al., 2015). The diluted sample is then counted a sec-
ond time to determine the number of cells that will be used to
normalize in vitro rate determinations. An evaluation of cell
yield and viability data suggested that variability in cell yield
determinations (within and among laboratories) was substan-
tially greater than the variability in measured cell viability
(Supplementary Table 4). This outcome is most likely due to dif-
ferences in sample handing, although difference in cell count-
ing technique could also contribute.
Methodological issues associated with the RT-HEP assay
may also explain the observed laboratory bias in measured CLIN
VITRO, INT values (Figure 4A). Although different users may han-
dle and count cells differently, individual users are likely to per-
form these steps in a consistent manner. In contrast, the RT-S9
assay is performed using a nearly identical amount of starting
material, obtained by diluting a previously characterized sam-
ple. The observed laboratory bias in RT-S9 study results
(Figure 4B) is therefore harder to explain, although differences
in technique (eg, pipetting, mixing of samples) could play a role.
Figure 7. Estimated hepatic clearance values (CLH) for MC, DM, 4NP, FEN, PYR, and CS. CLH values were calculated using a well-stirred liver model under two different
binding assumptions (fU¼ fU, P/fU, HEP or S9 or fU¼ 1.0; see text for details). In vitro intrinsic clearance rates used as inputs to these calculations were generated using cryo-
preserved rainbow trout hepatocytes (RT-HEP) or rainbow trout liver S9 fractions (RT-S9). Means calculated for all laboratories are shown as horizontal lines. Values
shown for MC, DM, 4NP, FEN, and CS represent data generated using chemical-specific lots of biological material (RT-HEP or RT-S9), whereas those given for PYR repre-
sent studies performed using all 5 lots of tested material. Boxes denote the 25th and 75th percentiles, whereas top and bottom whiskers extend up to 1.5 times the
interquartile range.
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The measured depletion rates for PYR provided only weak
evidence of a laboratory bias in study findings. However, the
utility of PYR as a reference chemical was demonstrated in sev-
eral instances where measured activity for PYR and another test
compound tested in parallel was found to be absent or greatly
reduced (for example, due to an omission of cofactors). Over
time, the repeated use of a reference chemical will result in his-
torical data that can be used to evaluate the “goodness” of each
assay result. Reference chemicals may also be useful when
comparing different fish species and strains, and could, in prin-
cipal, be used to “benchmark” different study results that are
due to inherent differences in metabolizing capacity. Finally, in-
corporation of a reference chemical may provide an important
means of demonstrating user proficiency, particularly for labo-
ratories that generate data as part of a regulatory submission.
When expressed in common units (CLIN VIVO, INT; L/d/kg fish),
intrinsic clearance rates determined using both assays were
similar (<3-fold difference for all chemicals except PYR). This
level of agreement was considered to be very good, given the
lot-to-lot differences in activity of RT-HEP and RT-S9, indicated
by study results for PYR (>1.6-fold; highest/lowest). Closer
agreement between the two systems (<2.6-fold difference for all
chemicals) was obtained when CLIN VIVO, INT values were extrap-
olated to estimates of hepatic clearance (CLH), primarily because
measured rates of activity were driving the well-stirred liver
model toward a flow-limited condition. There were no obvious
trends in the data which would suggest that one test system
consistently yields a higher or lower rate of CLIN VIVO, INT (and by
extension CLH). This finding contradicts earlier work (Han et al.,
2009), which suggested that CLH values predicted using RT-HEP
are consistently higher than those predicted using RT-S9.
Instead, the present work is consistent with a study by Fay et al.
(2017), which reported excellent agreement in CLH values for 6
PAHs predicted using both in vitro test systems.
BCFs calculated using measured rates of in vitro activity illus-
trate the utility of these methods for refining modeled bioaccu-
mulation predictions (Table 2). To date, comparisons between
measured and modeled BCFs have been compromised by a lack
of correspondence between fish species used to obtain in vitro
and in vivo data. Thus, all measured BCFs reported in Table 2
were obtained from species other than trout. Nevertheless, the
incorporation of in vitro data into an established one-
compartment model (Arnot and Gobas, 2003) resulted in BCFs
that are remarkably close to reported values, particularly under
the assumption of unrestricted clearance. Similar findings have
been reported by other research groups (Cowan-Ellsberry et al.,
2008; Dyer et al., 2008; Gomez et al., 2010; Han et al., 2007, 2009;
Laue et al., 2014).
The use of RT-S9 and RT-HEP for this application reflects the
existence of physiological and anatomical information required
to scale in vitro rates of clearance to the intact animal (Nichols
et al., 2006, 2013b). Additional work has been performed to de-
velop methods for cryopreservation of trout hepatocytes (Fay
et al., 2014a; Mingoia et al., 2010), facilitating their use across lab-
oratories. Ultimately, however, a need exists to develop similar
methods for other fish species in order to characterize species
difference with respect to metabolism impacts on chemical
bioaccumulation.
The results of this ring trial show that assays performed us-
ing RT-HEP and RT-S9 are highly reliable, and suggest that ei-
ther system may be used with confidence to inform chemical
bioaccumulation assessments for fish. Presently, it cannot be
said that one system is preferred for this application. Additional
work with a wider range of chemical substrates is needed to
determine whether the domain for applicability of these two
assays differs. Importantly, this effort highlights several issues
related to the demonstration of assay reliability, including
aspects of study design (number of laboratories, test chemicals,
replicates, etc.), assessment of starting biological material, and
the analysis of experimental findings (eg, assessment of bias).
As such, this study provides a template that could be employed
to evaluate other in vitro assays, including those used to mea-
sure intrinsic clearance in humans.
Standardized OECD test guidelines for in vitro determination
of intrinsic hepatic clearance using RT-HEP and RT-S9 are cur-
rently under review (OECD, 2017). Acceptance of these methods
by risk assessors will depend on additional studies demonstrat-
ing the accuracy of modeled bioaccumulation predictions, per-
formed using experimental designs that provide in vitro and
in vivo information for the same test species. Several investiga-
tions of this type are ongoing.
DISCLAIMER
This work describes an international ring trial of two in vitro as-
say systems. A report that describes the results of this ring trial
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operation and Development (OECD) and made publicly available
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2017). Portions of this work are excerpted from this earlier re-
port; however, the present contribution includes substantial
new material pertaining to data analysis and interpretation.
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online.
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